Tasly Holding Group Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 10,563

Employees

  • Stock Symbol
  • 600535

Stock Symbol

  • Investments
  • 56

  • Share Price
  • $2.10
  • (As of Friday Closing)

Tasly Holding Group General Information

Description

Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.

Contact Information

Website
www.tasly.com
Formerly Known As
Tianjin Tasly Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 2, Pujihe East Road
  • Beichen District
  • Tianjin, 300410
  • China
+86 022
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Number 2, Pujihe East Road
  • Beichen District
  • Tianjin, 300410
  • China
+86 022

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tasly Holding Group Stock Performance

As of 13-Nov-2026, Tasly Holding Group’s stock price is $2.10. Its current market cap is $3.13B with 1.49B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.10 $2.09 $1.90 - $2.40 $3.13B 1.49B 12.8M $0.12

Tasly Holding Group Financials Summary

As of 30-Sep-2026, Tasly Holding Group has a trailing 12-month revenue of $1.16B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,719,513 2,869,575 2,618,562 3,503,180
Revenue 1,160,571 1,145,336 1,184,334 1,226,030
EBITDA 207,539 246,691 213,940 240,426
Net Income 177,458 153,652 133,174 151,391
Total Assets 2,247,299 2,192,422 2,051,519 2,357,911
Total Debt 27,213 205,582 226,838 386,524
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tasly Holding Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tasly Holding Group‘s full profile, request access.

Request a free trial

Tasly Holding Group Patents

Tasly Holding Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026233184-A1 Bispecific chimeric antigen receptor and use thereof Pending 09-May-2025
WO-2026200003-A1 Peg-hmfgf-21 injection, preparation method therefor, and use thereof Pending 26-Mar-2025
WO-2026092393-A1 Mesenchymal stromal cell-based drug and use thereof in treatment of acute cerebral infarction Pending 28-Oct-2024
WO-2024022173-A1 Use of andrographolide and composition thereof in preparation of drug for treating hearing impairment Inactive 29-Jul-2022
US-20250075172-A1 Production method for bispecific antibody Pending 24-Dec-2021 C12N5/0018
To view Tasly Holding Group’s complete patent history, request access »

Tasly Holding Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tasly Holding Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tasly Holding Group‘s full profile, request access.

Request a free trial

Tasly Holding Group Investments & Acquisitions (56)

Tasly Holding Group’s most recent deal was a Early Stage VC with Rui Therapeutics for . The deal was made on 15-Sep-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Rui Therapeutics 15-Sep-2025 Early Stage VC Drug Discovery
Ribopeutic 10-Aug-2025 Early Stage VC Drug Discovery
Singular Medical 04-Feb-2025 Later Stage VC Diagnostic Equipment
LMBio 10-Dec-2024 Early Stage VC Biotechnology
Synceres Biosciences 15-Jun-2023 Early Stage VC Drug Discovery
You’re viewing 5 of 56 investments and acquisitions. Get the full list »

Tasly Holding Group ESG

Risk Overview

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Tasly Holding Group’s complete esg history, request access »

Tasly Holding Group Exits (18)

Tasly Holding Group’s most recent exit was on 06-Jul-2022 from ClouDr.. The exit was categorized as with 4 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
ClouDr. 06-Jul-2022 Completed
  • 4 buyers
HeartCare Medical 14-May-2020 Completed
  • 2 buyers
ClouDr. 08-Jan-2020 Completed
  • 9 buyers
ClouDr. 01-Sep-2019 Completed
  • 15 buyers
NovaBridge Biosciences 06-Jul-2018 Later Stage VC Completed
  • 9 buyers
You’re viewing 5 of 18 exits. Get the full list »

Tasly Holding Group Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Tasly Sainte Pharmaceutical Tianjin, China 2007
Tasly Capital Beijing, China 2007

Tasly Holding Group FAQs

  • When was Tasly Holding Group founded?

    Tasly Holding Group was founded in 1994.

  • Where is Tasly Holding Group headquartered?

    Tasly Holding Group is headquartered in Tianjin, China.

  • What is the size of Tasly Holding Group?

    Tasly Holding Group has 10,563 total employees.

  • What industry is Tasly Holding Group in?

    Tasly Holding Group’s primary industry is Pharmaceuticals.

  • Is Tasly Holding Group a private or public company?

    Tasly Holding Group is a Public company.

  • What is Tasly Holding Group’s stock symbol?

    The ticker symbol for Tasly Holding Group is 600535.

  • What is the current stock price of Tasly Holding Group?

    As of 13-Nov-2026 the stock price of Tasly Holding Group is $2.10.

  • What is the current market cap of Tasly Holding Group?

    The current market capitalization of Tasly Holding Group is $3.13B.

  • What is Tasly Holding Group’s current revenue?

    The trailing twelve month revenue for Tasly Holding Group is $1.16B.

  • What is Tasly Holding Group’s annual earnings per share (EPS)?

    Tasly Holding Group’s EPS for 12 months was $0.12.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process